Cargando…
Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342514/ https://www.ncbi.nlm.nih.gov/pubmed/25720581 http://dx.doi.org/10.1007/s00395-015-0475-8 |
_version_ | 1782359284149911552 |
---|---|
author | Zalewski, Jaroslaw Claus, Piet Bogaert, Jan Driessche, Nina Vanden Driesen, Ronald B. Galan, Diogo T. Sipido, Karin R. Buszman, Piotr Milewski, Krzysztof Van de Werf, Frans |
author_facet | Zalewski, Jaroslaw Claus, Piet Bogaert, Jan Driessche, Nina Vanden Driesen, Ronald B. Galan, Diogo T. Sipido, Karin R. Buszman, Piotr Milewski, Krzysztof Van de Werf, Frans |
author_sort | Zalewski, Jaroslaw |
collection | PubMed |
description | Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h of reperfusion were assigned to control (n = 8), postconditioning (n = 9) or cyclosporine A intravenous infusion 10–15 min before the end of ischemia (n = 8). Postconditioning was induced by 8 cycles of repeated 30-s balloon inflation and deflation. After 3 h of reperfusion magnetic resonance imaging, triphenyltetrazolium chloride/Evans blue staining and histopathology were performed. Microvascular obstruction (MVO, percentage of gadolinium-hyperenhanced area) was measured early (3 min) and late (12 min) after contrast injection. Infarct size with double staining was smaller in cyclosporine (46.2 ± 3.1 %, P = 0.016) and postconditioning pigs (47.6 ± 3.9 %, P = 0.008) versus controls (53.8 ± 4.1 %). Late MVO was significantly reduced by cyclosporine (13.9 ± 9.6 %, P = 0.047) but not postconditioning (23.6 ± 11.7 %, P = 0.66) when compared with controls (32.0 ± 16.9 %). Myocardial blood flow in the late MVO was improved with cyclosporine versus controls (0.30 ± 0.06 vs 0.21 ± 0.03 ml/g/min, P = 0.002) and was inversely correlated with late-MVO extent (R (2) = 0.93, P < 0.0001). Deterioration of left ventricular ejection fraction (LVEF) between baseline and 3 h of reperfusion was smaller with cyclosporine (−7.9 ± 2.4 %, P = 0.008) but not postconditioning (−12.0 ± 5.5 %, P = 0.22) when compared with controls (−16.4 ± 5.5 %). In the three groups, infarct size (β = −0.69, P < 0.001) and late MVO (β = −0.33, P = 0.02) were independent predictors of LVEF deterioration following ischemia/reperfusion (R (2) = 0.73, P < 0.001). Despite both cyclosporine A and postconditioning reduce infarct size, only cyclosporine A infusion had a beneficial effect on microvascular damage and was associated with better preserved LV function when compared with controls. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-015-0475-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4342514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-43425142015-03-04 Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion Zalewski, Jaroslaw Claus, Piet Bogaert, Jan Driessche, Nina Vanden Driesen, Ronald B. Galan, Diogo T. Sipido, Karin R. Buszman, Piotr Milewski, Krzysztof Van de Werf, Frans Basic Res Cardiol Original Contribution Postconditioning and cyclosporine A prevent mitochondrial permeability transition pore opening providing cardioprotection during ischemia/reperfusion. Whether microvascular obstruction is affected by these interventions is largely unknown. Pigs subjected to coronary occlusion for 1 h followed by 3 h of reperfusion were assigned to control (n = 8), postconditioning (n = 9) or cyclosporine A intravenous infusion 10–15 min before the end of ischemia (n = 8). Postconditioning was induced by 8 cycles of repeated 30-s balloon inflation and deflation. After 3 h of reperfusion magnetic resonance imaging, triphenyltetrazolium chloride/Evans blue staining and histopathology were performed. Microvascular obstruction (MVO, percentage of gadolinium-hyperenhanced area) was measured early (3 min) and late (12 min) after contrast injection. Infarct size with double staining was smaller in cyclosporine (46.2 ± 3.1 %, P = 0.016) and postconditioning pigs (47.6 ± 3.9 %, P = 0.008) versus controls (53.8 ± 4.1 %). Late MVO was significantly reduced by cyclosporine (13.9 ± 9.6 %, P = 0.047) but not postconditioning (23.6 ± 11.7 %, P = 0.66) when compared with controls (32.0 ± 16.9 %). Myocardial blood flow in the late MVO was improved with cyclosporine versus controls (0.30 ± 0.06 vs 0.21 ± 0.03 ml/g/min, P = 0.002) and was inversely correlated with late-MVO extent (R (2) = 0.93, P < 0.0001). Deterioration of left ventricular ejection fraction (LVEF) between baseline and 3 h of reperfusion was smaller with cyclosporine (−7.9 ± 2.4 %, P = 0.008) but not postconditioning (−12.0 ± 5.5 %, P = 0.22) when compared with controls (−16.4 ± 5.5 %). In the three groups, infarct size (β = −0.69, P < 0.001) and late MVO (β = −0.33, P = 0.02) were independent predictors of LVEF deterioration following ischemia/reperfusion (R (2) = 0.73, P < 0.001). Despite both cyclosporine A and postconditioning reduce infarct size, only cyclosporine A infusion had a beneficial effect on microvascular damage and was associated with better preserved LV function when compared with controls. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-015-0475-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-02-27 2015 /pmc/articles/PMC4342514/ /pubmed/25720581 http://dx.doi.org/10.1007/s00395-015-0475-8 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Contribution Zalewski, Jaroslaw Claus, Piet Bogaert, Jan Driessche, Nina Vanden Driesen, Ronald B. Galan, Diogo T. Sipido, Karin R. Buszman, Piotr Milewski, Krzysztof Van de Werf, Frans Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title | Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title_full | Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title_fullStr | Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title_full_unstemmed | Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title_short | Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
title_sort | cyclosporine a reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342514/ https://www.ncbi.nlm.nih.gov/pubmed/25720581 http://dx.doi.org/10.1007/s00395-015-0475-8 |
work_keys_str_mv | AT zalewskijaroslaw cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT clauspiet cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT bogaertjan cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT driesscheninavanden cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT driesenronaldb cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT galandiogot cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT sipidokarinr cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT buszmanpiotr cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT milewskikrzysztof cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion AT vandewerffrans cyclosporineareducesmicrovascularobstructionandpreservesleftventricularfunctiondeteriorationfollowingmyocardialischemiaandreperfusion |